Estrella Immunopharma ESLA
NASDAQ ESLA
$0.73 +0.18 (+32.15%)
At close: Oct 22, 2026 · 4:00 PM EDT

Estrella Immunopharma (ESLA) Total Debt (2022 - 2023)

Updated

Estrella Immunopharma (ESLA) posted Total Debt of $300,000 for Q1 2024, up 9.9% from the prior quarter.

Analysis

Estrella Immunopharma (ESLA) Total Debt (2022 - 2023) Analysis & Trends

At the end of FY2023, Estrella Immunopharma's Total Debt came in at $273,066.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 54.91 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 44.65 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 70.82 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 53.91 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 9.59 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 32.35 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 57.30 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 26.25 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 63.19 Bn
10 Estrella Immunopharma 30.10 Mn 25.01 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 300,000.00
Jun 30, 2023 273,066.00
Mar 31, 2023 136,533.00
Sep 30, 2022 498,600.00
API Access

Estrella Immunopharma Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=ESLA&period=max&api_key=YOUR_API_KEY